MSR India (508922)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹8.87 |
| Market Cap | ₹56.56 Cr |
| P/E Ratio | 0 |
| ROCE | -5.44% |
| ROE | -4.58% |
| Dividend Yield | 0% |
| Profit Growth | -107.14% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹2.23 — ₹8.87 |
| Sector | Industrial Products |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Every year I read a mountain of financials, and MSR India does not pass the first page. The latest quarter shows sales of ₹0 crore and profit of ₹-0 crore. Over the past year, profit growth has collapsed by over 107% while return on equity sits at -4.58% and ROCE at -5.44%. Mr. Market has nonetheless marked the stock up to ₹8.87, the top of its 52-week range, giving a market cap of ₹57 crore. That is not value investing; that is price speculation. A zero P/E and absent book value tell me there is no dependable earnings power and no balance-sheet anchor I can trust. The Piotroski F-Score of 2/9 is a distress signal—nine financial-health tests and only two pass. There is no dividend to compensate while I wait. In Buffett's language, this is a cigar butt with a soggy wrapper—and perhaps not even one smoke left. The industry, aluminium, copper and zinc, has a genuine long-term future in India's infrastructure buildout, but a company cannot benefit until it can actually sell something and earn a return above its cost of capital. If operations are being restarted, this could be a turnaround, but I need evidence: consecutive quarters of real sales, positive operating cash flow, a proper audited balance sheet, and promoter skin in the game. Until those appear, my intrinsic value column stays blank. In Graham's terms, there is no margin of safety; there is only a margin of hope. I would rather lose an opportunity than lose capital.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer